Abstract:【Objective】To study the effect of a selective COX-2 inhibitor NS-398 combined with chemotherapy agent cisplatin on the proliferation of human lung adenocarcinoma cell lines,and the mechanism of the combined use of the two agents.【Methods】the effect of synergistic use of NS-398 and cisplatin on the proliferation of human lung adenocarcinoma cell lines was discussed by MTT growth assay,the apoptosis assay and the cell cycle distribution were analyzed by fluorescence staining of Acridine orange(AO) and Ethidium bromide(EB) and by the flow cytometry.The differential expressed proteins in the human lung adenocarcinoma cells with the combined use of NS398 and cisplatin were separated by means of immobilized pH gradient-based two-dimensional gel electrophoresis (2-DE),then 19 proteins among them were identified by peptide mass fingerprint(PMF) based on matrix-assisted laser desorption/ionization time of flight mass spectrometry(MALDI-TOF-MS) and database searching.【Results】NS-398 in combination with cisplatin resulted in a reduction of cisplatin′ IC50 by 43.34%~69.61%,the effects of NS-398 combined with cisplatin ranged from slight synergism to synergism.The apoptotic ratios at 24 h and 48 h were higher than that of the control group.In the group with the combined use of NS-398 and cisplatin there were 22 down-regulated proteins,and 2 up-regulated proteins compared with the control group.and the changes didn′t occurred in the cisplatin group or NS-398 group as well.There were 25 proteins only appearing in the combined group,whereas 17 proteins disappeared in the combined group.19 proteins among the proteins were selected on the basis of the intensity and the significant difference in abundance of changes and identified by means of MALDITOF-MS.Some proteins identified were cytokreratins,some proteins were associated with proliferation and apoptosis,others were involved in the metabolism of the cells.【Conclusion】Combination studies showed synergistic interactions for NS-398 with cisplatin.NS-398 would enhance the chemosensitivity of lung adenocarcinoma cells to cisplatin.The enhanced apoptosis may be involved in the synergistic effect of NS-398 and cisplatin in the growth inhibition of lung adenocarcinoma cells.The down-regulation of HSP 90 and Triosephosphate-isomerase were related to the enhanced growth inhibition of the lung-cancer cells by the combined use of the two agents.

Mechanism and effect of selective cyclooxygenase-2 inhibitor NS-3 9 8 on human cervical carcinoma cells

Mechanism and Effect of Selective Cyclooxygenase-2 Inhibitor NS-398 on Human Cervical Carcinoma Cells

Effects of NS398, an inhibitor of cyclooxygenase 2, on the growth and apoptosis of human squamous cell carcinoma cell line Tca8113

Growth inhibition of NS-398 combined with cisplatin on human lung adenocarcinoma cells and its mechanism]

Study of mechanism in growth inhibition of human lung Study of mechanism in growth inhibition of human lung adenocarcinoma with combined use of NS-398 and cisplatin

RETRACTED ARTICLE: Effect of NS-398, a Cyclooxygenase-2 Selective Inhibitor, on the Cytotoxicity of Cytotoxic T Lymphocytes to Ovarian Carcinoma Cells

Intervention Effects of Nedaplatin and Cisplatin on Proliferation and Apoptosis of Human Tumour Cells in Vitro

STUDY ON THE EXPRESSION OF CYCLOOXYGENASE-2 IN HEPATOCELLULAR CARCINOMA CELL LINES AND ON THE GROWTH INHIBITION EFFECT OF NS-398

In Vitro Enhancement of Radiation-Induced Apoptosis in Human Hepatoma Cell Line HepG2 by a Selective Inhibitor of Cyclooxygenase-2 Enzyme NS -398

[Effects of Cyclooxygenase-2 Antisense Vector on Proliferation and Sensitivity to Cisplatin of H1299 Cells].

Effect of Taxotere Combination with Celecoxib on Proliferation of NSCLC Cell

Effect of Selective Cyclooxygenase-2 Inhibitor NS-398 on Cell Apoptosis in K562 Cells and Its Underlying Mechanism

Specific COX-2 Inhibitor NS398 Induces Apoptosis in Human Liver Cancer Cell Line HepG2 Through BCL-2

[Effects of Selective Cyclooxygenase-2 Inhibitor NS-398 on 5-Fluorouracil Chemotherapy and Progression of Colon Cells: an Experimental Study].

Effects of Docetaxel, Oxaliplatin and Their Combination on HeLa Strain of Cervical Cancer

[Anticancer Effect of SN-38 Combined with Sorafenib on Hepatocellular Carcinoma in Vitro and Its Mechanism].

Combination of Octreotide with Specific Cyclooxygenase-2 Inhibitor Enhances the Inhibitory Effect on Growth of Human Hepatocellular Carcinoma

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Growth-inhibitory Effects of Selective Cyclooxygenase-2 Inhibitor on Colon Cancer Cells and Its Possible Mechanisms

Effect of Selective Cyclooxygenase-2 Inhibitor NS398 on the Proliferation and Apoptosis of Prostate Cancer Cell Line PC0-3 in Vitro

Effect of Nimesulide on Proliferation and Apoptosis of Human Hepatoma Smmc-7721 Cells